Cargando…

Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers

Recurrence of focal segmental glomerulosclerosis (FSGS) is common after kidney transplantation. Plasmapheresis (PP) is considered to be the most effective treatment; however, results are variable and relapse is common after stopping plasmapheresis. Here, we report an unusual case of recurrent FSGS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, S. B., Sethi, S. K., Jha, P., Duggal, R., Kher, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358161/
https://www.ncbi.nlm.nih.gov/pubmed/28356673
http://dx.doi.org/10.4103/0971-4065.183600
_version_ 1782516177275191296
author Bansal, S. B.
Sethi, S. K.
Jha, P.
Duggal, R.
Kher, V.
author_facet Bansal, S. B.
Sethi, S. K.
Jha, P.
Duggal, R.
Kher, V.
author_sort Bansal, S. B.
collection PubMed
description Recurrence of focal segmental glomerulosclerosis (FSGS) is common after kidney transplantation. Plasmapheresis (PP) is considered to be the most effective treatment; however, results are variable and relapse is common after stopping plasmapheresis. Here, we report an unusual case of recurrent FSGS, who achieved complete remission with angiotensin receptor blocker therapy.
format Online
Article
Text
id pubmed-5358161
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53581612017-03-29 Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers Bansal, S. B. Sethi, S. K. Jha, P. Duggal, R. Kher, V. Indian J Nephrol Case Report Recurrence of focal segmental glomerulosclerosis (FSGS) is common after kidney transplantation. Plasmapheresis (PP) is considered to be the most effective treatment; however, results are variable and relapse is common after stopping plasmapheresis. Here, we report an unusual case of recurrent FSGS, who achieved complete remission with angiotensin receptor blocker therapy. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5358161/ /pubmed/28356673 http://dx.doi.org/10.4103/0971-4065.183600 Text en Copyright: © 2017 Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Bansal, S. B.
Sethi, S. K.
Jha, P.
Duggal, R.
Kher, V.
Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
title Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
title_full Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
title_fullStr Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
title_full_unstemmed Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
title_short Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
title_sort remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358161/
https://www.ncbi.nlm.nih.gov/pubmed/28356673
http://dx.doi.org/10.4103/0971-4065.183600
work_keys_str_mv AT bansalsb remissionofposttransplantfocalsegmentalglomerulosclerosiswithangiotensinreceptorblockers
AT sethisk remissionofposttransplantfocalsegmentalglomerulosclerosiswithangiotensinreceptorblockers
AT jhap remissionofposttransplantfocalsegmentalglomerulosclerosiswithangiotensinreceptorblockers
AT duggalr remissionofposttransplantfocalsegmentalglomerulosclerosiswithangiotensinreceptorblockers
AT kherv remissionofposttransplantfocalsegmentalglomerulosclerosiswithangiotensinreceptorblockers